AI-generated summary
The authors randomized 19 hands with carpal tunnel syndrome in rheumatoid arthritis patients to low level laser therapy or placebo laser over 10 days. They report greater improvement in pain score and functional status in the laser group at 3 months, with no significant differences in other measures. The authors note the study was small and the conclusion that laser may be a useful alternative appears to be their interpretation.
- Participants
- 19
- Who or what was studied
- Patients with rheumatoid arthritis and carpal tunnel syndrome (19 hands; 10 in the laser group, 9 in the placebo group)
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The abstract describes a small sample of 19 hands split across two groups, so the findings may be limited in statistical strength.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on smw.ch.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Power
- 50 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Visual analogue scale, Power output, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.